Navigation Links
Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting
Date:12/2/2009

s occurred in patients with multiple comorbidities and who were in advanced stages of their hematologic disorders. There have also been reports of renal tubulopathy in patients treated with EXJADE. Give particular attention to monitoring serum creatinine in patients who: are at increased risk of complications, have pre-existing renal conditions, are elderly, have comorbid conditions, or are receiving medicinal products that depress renal function.

Assess serum creatinine in duplicate before initiating therapy to establish a reliable pretreatment baseline, due to variations in measurements. Monitor serum creatinine monthly thereafter. In patients with additional renal risk factors (those who are at increased risk of complications, have pre-existing renal conditions, are elderly, have comorbid conditions, or are receiving medicinal products that depress renal function), monitor serum creatinine weekly during the first month after initiation or modification of therapy and monthly thereafter. Nonprogressive increases in serum creatinine have been noted in 38% of EXJADE-treated patients, compared to 14% of deferoxamine-treated patients in Study 1 and 36% vs 22%, respectively in Study 3, and appear to be dose related. These increases were within the normal range in 94% of patients. EXJADE dosages were adjusted when serum creatinine elevations were detected during the study.

Consider dose reduction, interruption, or discontinuation for elevations in serum creatinine. For adult patients, reduce the daily dose of EXJADE by 10 mg/kg if a rise in serum creatinine to >33% above the average of the pretreatment measurements is seen at 2 consecutive visits, and cannot be attributed to other causes. For pediatric patients, reduce the dose by 10 mg/kg if serum creatinine levels rise above the age-appropriate upper limit of normal at 2 consecutive visits. If there is a progressive increase in serum creatinine beyond the age-appropriate upper limit of normal
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  Transportation ... provider, announces winning the SDCE100 Award for ... & Demand Chain Executive magazine. Transportation ... consumer goods distributor quantify and control supply ... their highly competitive market. Deploying Transportation Insight,s ...
(Date:5/28/2015)... DUBLIN , May 28, 2015 /PRNewswire/ ... ) has announced the addition of Jain ... and Commercial Aspects"  to their offering.  ,     ... medicine or individualized treatment is to match ... and, in some cases, even to design ...
(Date:5/28/2015)... National Community Pharmacists Association (NCPA) CEO ... statement in response to a new report ... a number of generic drug costs increased substantially in ... previously expressed by NCPA and underscores the need for ... medications. Moreover, a 2015 survey of 700 community pharmacists ...
Breaking Medicine Technology:Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 2Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 3Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 4Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 3NCPA: AARP Drug Pricing Report Reiterates Need for Fair Generic Drug Reimbursements 2
... BETHLEHEM, Pa., Nov. 14, 2011 MedClean Technologies, Inc. (OTC ... for the 2011 third quarter for the period ended September ... : The company has dramatically improved its ... the following key metrics, representing tangible progress: ...
... /PRNewswire-Asia-First Call/ -- American Oriental Bioengineering, Inc. (NYSE: ... company dedicated to improving health through the development, manufacture ... over the counter ("OTC") products, today announced that it ... call at 8:00 am EST on Tuesday, November 15, ...
Cached Medicine Technology:MedClean Technologies Announces Third Quarter Results 2MedClean Technologies Announces Third Quarter Results 3MedClean Technologies Announces Third Quarter Results 4MedClean Technologies Announces Third Quarter Results 5MedClean Technologies Announces Third Quarter Results 6MedClean Technologies Announces Third Quarter Results 7American Oriental Bioengineering to Hold Third Quarter 2011 Earnings Conference Call at 8:00 AM on November 15, 2011 2
(Date:5/28/2015)... Are policies that spell out when Medicare pays ... pain for seniors? That’s what a study published this ... to figure out, and its findings could have implications ... study, “Observation Encounters and Subsequent Nursing Facility Stays,” ... Medicare policies that distinguish between an “inpatient” hospital stay ...
(Date:5/28/2015)... 2015 The Paw Project, ... dramatic billboard intended to educate the Oregon public about ... busy intersection of Market Street and Park Avenue in ... You’re for De-clawing Cats, Raise Your Hand,” depicts a ... joint, providing a graphic and anatomically-correct representation of the ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 " Trends Investing ... Biz Report, which takes a look at small, medium, and ... the host of NewsWatch and business expert, conducted the business ... guides users to where they should invest their money. , ... sound concept. But doing it and knowing how to ...
(Date:5/28/2015)... FL (PRWEB) May 28, 2015 Nidra Herbal ... incredibly gentle on the body. A non-addictive supplement, Nidra Herbal ... blend of natural ingredients will leave users with a real ... system of care , Ayurveda, which translates as the “Science ... than 5,000 years ago and is a holistic system of ...
(Date:5/28/2015)... May 28, 2015 Healthpointe is ... now be offering Echocardiography Examinations to patients with ... by renowned Qualified Medical Examiner and licensed Cardiologist, ... test is a non-invasive and cost-effective approach to ... critically ill or have undergone surgery. Also ...
Breaking Medicine News(10 mins):Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 3Health News:Declawing is Cruel, Education is the Key - Says the Paw Project 2Health News:Declawing is Cruel, Education is the Key - Says the Paw Project 3Health News:An Application to Learn Where to Invest Money was Featured on NewsWatch Television 2Health News:Ayurveda Herba Corp’s Revolutionary Herbal Sleep Supplement is Now Available from Amazon.com 2Health News:Healthpointe Is Now Offering Echocardiography Examinations at the Anaheim Clinic. 2
... to Enhance Patient Safety, Efficiency, SAN RAMON, ... global services firm that specializes in enabling,transformation of ... it has signed a $1.5 million five-year contract ... that includes 331 skilled nursing,facilities and 19 assisted ...
... 29 Sun Pharmaceutical Industries,Ltd. (Reuters: SUN.BO, Bloomberg: ... letter to Barrie Levitt, M.D., Chairman of Taro ... purported,termination of the May 18, 2007 merger agreement ... Director of Sun, said, "Taro is,not entitled to ...
... time makes ovaries lose their ability to produce estrogens ... In this stage, when menstruation cesses, there appear physical ... dryness, articulation and bone pain, headaches, insomnia, sadness, depression ... Spain, the average age for the cessation of the ...
... Winning Entries From Oncology on Canvas(SM) To Be On ... is Not a Dress,Rehearsal," "More Than a Statistic," "Why ... represented in art and narrative at an exhibit,featuring selected ... a Cancer Journey Art Competition and Exhibition. The art ...
... Stress, hormone imbalances to blame for a condition many women suffer ... ... day, women worldwide,look in the mirror, and where they used to see ... hair loss, they try,to hide it with make-up, creative hairstyles, or sometimes ...
... INDIANAPOLIS, May 29 People who favor,flip-flops as ... lower leg pain and a change in their stride, ... of the American College,of Sports Medicine (ACSM) in Indianapolis., ... with the observation,that most people appear to be wearing ...
Cached Medicine News:Health News:Keane Wins $1.5 Million Electronic Medical Record (EMR) Implementation with Leading Long-Term Care Company 2Health News:Keane Wins $1.5 Million Electronic Medical Record (EMR) Implementation with Leading Long-Term Care Company 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 2Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 4Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 5Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 6Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 7Health News:Post-menopausal therapy to improve women's quality of life 2Health News:Art Exhibit Honors National Cancer Survivors Day 2Health News:Art Exhibit Honors National Cancer Survivors Day 3Health News:Hair Loss Is on the Rise, and Women Are Among the Hardest Hit 2Health News:Flip-Flops, Heels Examined for Performance, Impact 2Health News:Flip-Flops, Heels Examined for Performance, Impact 3